AU2003287081A8 - Clofarabine and taxane chemotherapy combination - Google Patents
Clofarabine and taxane chemotherapy combinationInfo
- Publication number
- AU2003287081A8 AU2003287081A8 AU2003287081A AU2003287081A AU2003287081A8 AU 2003287081 A8 AU2003287081 A8 AU 2003287081A8 AU 2003287081 A AU2003287081 A AU 2003287081A AU 2003287081 A AU2003287081 A AU 2003287081A AU 2003287081 A8 AU2003287081 A8 AU 2003287081A8
- Authority
- AU
- Australia
- Prior art keywords
- clofarabine
- chemotherapy combination
- taxane chemotherapy
- taxane
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41893802P | 2002-10-16 | 2002-10-16 | |
US60/418,938 | 2002-10-16 | ||
US45951203P | 2003-04-01 | 2003-04-01 | |
US60/459,512 | 2003-04-01 | ||
PCT/US2003/032516 WO2004035034A2 (en) | 2002-10-16 | 2003-10-14 | Clofarabine and taxane chemotherapy combination |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003287081A1 AU2003287081A1 (en) | 2004-05-04 |
AU2003287081A8 true AU2003287081A8 (en) | 2004-05-04 |
Family
ID=32110200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003287081A Abandoned AU2003287081A1 (en) | 2002-10-16 | 2003-10-14 | Clofarabine and taxane chemotherapy combination |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003287081A1 (en) |
WO (1) | WO2004035034A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1875936B (en) * | 2006-07-18 | 2010-05-19 | 济南康泉医药科技有限公司 | Anticancer sustained release agent containing clorfarabine and cytotoxic drug |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5034518A (en) * | 1989-05-23 | 1991-07-23 | Southern Research Institute | 2-fluoro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine nucleosides |
US6441026B1 (en) * | 1993-11-08 | 2002-08-27 | Aventis Pharma S.A. | Antitumor compositions containing taxane derivatives |
US20020182204A1 (en) * | 2001-03-23 | 2002-12-05 | Marie-Christine Bissery | Combination of a taxane and a cyclin-dependent kinase |
-
2003
- 2003-10-14 AU AU2003287081A patent/AU2003287081A1/en not_active Abandoned
- 2003-10-14 WO PCT/US2003/032516 patent/WO2004035034A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004035034A2 (en) | 2004-04-29 |
WO2004035034A3 (en) | 2004-07-22 |
AU2003287081A1 (en) | 2004-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1545481A4 (en) | Combination chemotherapy compositions and methods | |
ZA200603882B (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides | |
IL175491A0 (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides | |
EP1539941A4 (en) | Adzymes and uses thereof | |
HK1088837A1 (en) | Clk-peptide and slk-peptide | |
EP1469860A4 (en) | Anti-cancer combination and use thereof | |
IL172195A0 (en) | Thiotungstate analogues and uses thereof | |
GB0207362D0 (en) | Chemotherapy | |
IL165112A0 (en) | Variant integrinpolypeptides and thereof | |
GB2415089B (en) | Piezoelectric-transformer and carrier arrangement | |
AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
AU2003227074A8 (en) | Perspiration insert | |
AU2003287081A8 (en) | Clofarabine and taxane chemotherapy combination | |
AU2003302173A8 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
EP1487547A4 (en) | Physical interaction means and related uses thereof | |
EP1660088A4 (en) | Pyridomorphinans, pyridazinomorphinans and use thereof | |
AU2003301245A8 (en) | Clofarabine and camptothecin chemotherapy combination | |
GB0327814D0 (en) | Aerosolisable composition and delivery system | |
AU2003277416A1 (en) | Clofarabine and platinum chemotherapy combination | |
GB0427089D0 (en) | Interaction between HSP90 and P50CDC37 | |
GB0209413D0 (en) | Armrest | |
AU2003216442A8 (en) | Enkurin and uses thereof | |
AU2003228397A8 (en) | Hausp-p53 interaction and uses thereof | |
EP1699809A4 (en) | Amniotic-derived peptide and uses thereof | |
GB0329309D0 (en) | Easy-birth re arch-1 and half arch and arch-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |